Nevertheless, regenerative approaches such as PRP, GH, G-CSF, and stem cell-based therapies have demonstrated potential benefits for infertile women with thin endometrium who do not respond to conventional hormonal or vasoactive treatments (Figure 1). The gene discussed is CSF3; the disease is Infertility.